US Stock MarketDetailed Quotes

ALRN Aileron Therapeutics

Watchlist

4.0000
0.00000.00%

Close Nov 4 16:00 ET

86.66MMarket Cap-1290P/E (TTM)

Aileron Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-169.22%-8.39M

-13.09%-5.27M

20.34%-19.81M

-135.68%-10.39M

76.47%-1.64M

45.19%-3.12M

40.24%-4.66M

-4.68%-24.87M

29.51%-4.41M

3.98%-6.97M

Net income from continuing operations

-400.39%-8.94M

-48.84%-7.11M

42.43%-15.73M

-61.40%-7.34M

71.31%-1.83M

77.64%-1.79M

43.26%-4.78M

-4.45%-27.33M

33.12%-4.55M

5.01%-6.37M

Operating gains losses

----

---36K

---10K

---42K

--0

--16K

----

Depreciation and amortization

-66.67%4K

37.21%59K

-29.59%119K

20.93%52K

-72.09%12K

-71.43%12K

4.88%43K

39.67%169K

7.50%43K

10.26%43K

Change In working capital

114.03%223K

813.10%1.63M

-1,381.19%-5.38M

-1,624.27%-3.55M

98.93%-11K

-190.54%-1.59M

-118.10%-229K

73.55%420K

-57.25%-206K

18.79%-1.02M

-Change in prepaid assets

-589.80%-480K

-25.10%185K

-96.84%51K

-84.78%144K

-7.09%-438K

-86.93%98K

-24.23%247K

654.30%1.61M

1,884.91%946K

73.06%-409K

-Change in payables and accrued expense

123.95%404K

141.76%195K

-404.14%-5.36M

-225.31%-3.64M

173.37%427K

-262.84%-1.69M

-16.75%-467K

-270.79%-1.06M

-2,229.17%-1.12M

-303.50%-582K

-Change in other current assets

--183K

5,320.83%1.3M

---3K

---27K

--0

--24K

--0

-Change in other current liabilities

--116K

-45.45%-48K

49.61%-65K

5.88%-32K

--0

-6.45%-33K

-95.45%-129K

-13.33%-34K

-13.79%-33K

Cash from discontinued investing activities

Operating cash flow

-169.22%-8.39M

-13.09%-5.27M

20.34%-19.81M

-135.68%-10.39M

76.47%-1.64M

45.19%-3.12M

40.24%-4.66M

-4.68%-24.87M

29.51%-4.41M

3.98%-6.97M

Investing cash flow

Cash flow from continuing investing activities

-38.79%16.2M

-102.02%-96K

-87.04%542K

44.95%8.5M

-37.76%7.25M

173.67%26.46M

111.64%4.76M

2.27%4.18M

Net PPE purchase and sale

----

--42K

--0

----

--0

----

Net business purchase and sale

----

---96K

----

--0

----

Net investment purchase and sale

--0

-38.58%16.25M

--0

-88.04%500K

44.95%8.5M

-37.76%7.25M

173.85%26.46M

111.64%4.76M

3.82%4.18M

Cash from discontinued investing activities

Investing cash flow

--0

-38.79%16.2M

-102.02%-96K

-87.04%542K

44.95%8.5M

-37.76%7.25M

173.67%26.46M

111.64%4.76M

2.27%4.18M

Financing cash flow

Cash flow from continuing financing activities

15.79M

Net common stock issuance

----

--0

----

--0

Net other financing activities

----

--15.79M

----

Cash from discontinued financing activities

Financing cash flow

----

--15.79M

--0

----

--0

Net cash flow

Beginning cash position

54.55%12.07M

232.21%17.34M

43.97%5.22M

148.64%12.09M

72.38%13.19M

4.47%7.81M

43.97%5.22M

-52.55%3.63M

-36.23%4.86M

-28.96%7.65M

Current changes in cash

83.40%9.87M

-303.59%-5.27M

664.24%12.18M

1,394.93%5.31M

60.63%-1.1M

2,907.82%5.38M

-32.74%2.59M

139.71%1.59M

108.87%355K

11.32%-2.79M

Effect of exchange rate changes

----

---63K

----

--0

----

End cash Position

66.33%21.94M

54.55%12.07M

232.21%17.34M

148.64%12.09M

72.38%13.19M

4.47%7.81M

43.97%5.22M

-36.23%4.86M

Free cash flow

-169.22%-8.39M

-13.09%-5.27M

20.34%-19.81M

-135.68%-10.39M

76.47%-1.64M

45.19%-3.12M

40.24%-4.66M

-3.99%-24.87M

29.51%-4.41M

4.05%-6.97M

Currency Unit

USD

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-169.22%-8.39M	-13.09%-5.27M	20.34%-19.81M	-135.68%-10.39M	76.47%-1.64M	45.19%-3.12M	40.24%-4.66M	-4.68%-24.87M	29.51%-4.41M	3.98%-6.97M
Net income from continuing operations	-400.39%-8.94M	-48.84%-7.11M	42.43%-15.73M	-61.40%-7.34M	71.31%-1.83M	77.64%-1.79M	43.26%-4.78M	-4.45%-27.33M	33.12%-4.55M	5.01%-6.37M
Operating gains losses	----	----	---36K	---10K	---42K	--0	--16K	----	----	----
Depreciation and amortization	-66.67%4K	37.21%59K	-29.59%119K	20.93%52K	-72.09%12K	-71.43%12K	4.88%43K	39.67%169K	7.50%43K	10.26%43K
Change In working capital	114.03%223K	813.10%1.63M	-1,381.19%-5.38M	-1,624.27%-3.55M	98.93%-11K	-190.54%-1.59M	-118.10%-229K	73.55%420K	-57.25%-206K	18.79%-1.02M
-Change in prepaid assets	-589.80%-480K	-25.10%185K	-96.84%51K	-84.78%144K	-7.09%-438K	-86.93%98K	-24.23%247K	654.30%1.61M	1,884.91%946K	73.06%-409K
-Change in payables and accrued expense	123.95%404K	141.76%195K	-404.14%-5.36M	-225.31%-3.64M	173.37%427K	-262.84%-1.69M	-16.75%-467K	-270.79%-1.06M	-2,229.17%-1.12M	-303.50%-582K
-Change in other current assets	--183K	5,320.83%1.3M	---3K	---27K	--0	--0	--24K	--0	--0	--0
-Change in other current liabilities	--116K	-45.45%-48K	49.61%-65K	5.88%-32K	--0	--0	-6.45%-33K	-95.45%-129K	-13.33%-34K	-13.79%-33K
Cash from discontinued investing activities
Operating cash flow	-169.22%-8.39M	-13.09%-5.27M	20.34%-19.81M	-135.68%-10.39M	76.47%-1.64M	45.19%-3.12M	40.24%-4.66M	-4.68%-24.87M	29.51%-4.41M	3.98%-6.97M
Investing cash flow
Cash flow from continuing investing activities	0	0	-38.79%16.2M	-102.02%-96K	-87.04%542K	44.95%8.5M	-37.76%7.25M	173.67%26.46M	111.64%4.76M	2.27%4.18M
Net PPE purchase and sale	----	----	--42K	--0	----	----	----	--0	--0	----
Net business purchase and sale	----	----	---96K	----	----	----	----	--0	----	----
Net investment purchase and sale	--0	--0	-38.58%16.25M	--0	-88.04%500K	44.95%8.5M	-37.76%7.25M	173.85%26.46M	111.64%4.76M	3.82%4.18M
Cash from discontinued investing activities
Investing cash flow	--0	--0	-38.79%16.2M	-102.02%-96K	-87.04%542K	44.95%8.5M	-37.76%7.25M	173.67%26.46M	111.64%4.76M	2.27%4.18M
Financing cash flow
Cash flow from continuing financing activities			15.79M	15.79M	0			0	0	0
Net common stock issuance	----	----	----	----	--0	----	----	----	----	--0
Net other financing activities	----	----	--15.79M	----	----	----	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	----	----	--15.79M	--15.79M	--0	----	----	--0	--0	--0
Net cash flow
Beginning cash position	54.55%12.07M	232.21%17.34M	43.97%5.22M	148.64%12.09M	72.38%13.19M	4.47%7.81M	43.97%5.22M	-52.55%3.63M	-36.23%4.86M	-28.96%7.65M
Current changes in cash	83.40%9.87M	-303.59%-5.27M	664.24%12.18M	1,394.93%5.31M	60.63%-1.1M	2,907.82%5.38M	-32.74%2.59M	139.71%1.59M	108.87%355K	11.32%-2.79M
Effect of exchange rate changes	----	----	---63K	----	----	----	----	--0	----	----
End cash Position	66.33%21.94M	54.55%12.07M	232.21%17.34M	232.21%17.34M	148.64%12.09M	72.38%13.19M	4.47%7.81M	43.97%5.22M	43.97%5.22M	-36.23%4.86M
Free cash flow	-169.22%-8.39M	-13.09%-5.27M	20.34%-19.81M	-135.68%-10.39M	76.47%-1.64M	45.19%-3.12M	40.24%-4.66M	-3.99%-24.87M	29.51%-4.41M	4.05%-6.97M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	--	--	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data